PCI with DES: how to further improve outcomes?

Session comprising selected EuroPCR 2015 abstract submissions

Presentations available when logged in:

  • 13-year results of the DESIRE registry (DES In the REal world): the longest available clinical follow-up of a cohort of real-world patients treated...
  • 5-year follow-up of safety and efficacy of the Resolute zotarolimus-eluting stent: insights from the RESOLUTE global clinical trial programme in ap...
  • 3-year results from the multicentre Promus Element European post-approval registry (PE-PROVE): outcomes in 1,010 unselected patients treated with a...
  • BIOFLOW-III: an all-comer registry with a sirolimus-eluting stent, presentation of 1-year target lesion failure data in patients with complex lesions
  • Comparative evaluation of high-risk ACS and stable patients treated with bioresorbable polymer DES
  • Biolimus-eluting stent versus everolimus-eluting stent use in patients undergoing PCI: the 12-month outcome